Lord’s Mark Industries Limited has announced the successful completion and shipment of its first MedTech shipment to the United States, valued at USD 1 million. The order, executed through Lord’s Mark Industries Ltd., marks a notable step in the company’s international expansion and reflects the growing presence of Indian-made healthcare technology in global markets.
The shipment includes Contactless Remote Patient Monitoring (RPM) devices and AI-based Early Warning Systems (EWS), developed and manufactured in India. These systems integrate real-time monitoring, predictive analytics, and Electronic Health Records (EHR) support to assist healthcare providers in making timely clinical decisions.
“This milestone reinforces India’s position as a hub for high-quality MedTech innovation,” said Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Ltd. “Our first US shipment is more than an export — it marks India’s MedTech leadership taking shape globally. We are building world-class healthcare technologies that meet the world’s toughest standards, positioning Lord’s Mark Industries Ltd. as a global force and Indian innovation as a trusted benchmark in international markets.”
Lord's Mark Industries Ltd. operates through subsidiaries including LordsMed, Lord's Mark Biotech Pvt. Ltd., and Lords Mark Microbiotech Pvt. Ltd. The company has been expanding its footprint across diagnostics, pharmaceuticals, and genome testing, focusing on building capacity across multiple segments of the healthcare sector.
Established in 1998, Lord’s Mark Industries Ltd. has evolved from a diversified business entity into a growing player in healthcare technology and diagnostics.
To know more - www.lordsmark.com
Moneycontrol Journalists are not involved in creation of this article.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!